Recently, identified tumor markers called gastrin-17 (G-17) and aldehyde dehydrogenase 1 (ALDH1) have synergistic effects on the development and growth of tumors, and they work together to drive the progression of chronic atrophic gastritis to gastric cancer (2, 3). Here, ALDH1A1 is linked to gastritis.